Cybersecurity Leads $2.5 B in U.S. Startup Funding Week, AI and Health Follow
Two $400 million rounds for Island and Cyera top a week of mega-deals across AI, biotech and neurotechnology.

The week of Sept. 19-25, 2026 delivered a surge of large-scale financing for U.S. startups, with cybersecurity firms Island and Cyera each closing $400 million rounds that together accounted for more than one-third of the $2.5 billion raised by the ten biggest deals. The activity underscores continued investor appetite for security solutions as AI and data-intensive applications expand across enterprises.
Dallas-based Island announced a Series F round of $400 million led by Evolution Equity Partners, pushing its post-money valuation to $6.4 billion, more than double the figure reported in 2024. Island builds tools that protect digital operations for large organizations, a market that has grown sharply as remote work and cloud adoption increase attack surfaces. New York-based Cyera secured a $400 million Series G extension, also fronted by Evolution Equity Partners with participation from Goldman Sachs Growth Equity. The funding brings Cyera’s total capital to $2.7 billion and reinforces its platform that secures data accessed by both human users and AI agents.
Beyond security, foundational AI continued to attract capital. San Francisco’s Snorkel AI raised $350 million in a Series E led by Insight Partners and S32, valuing the seven-year-old company at $3.2 billion. Snorkel’s technology helps AI labs generate specialized training data and simulation environments, and the firm now reports annual recurring revenue exceeding $375 million. The round signals confidence in infrastructure that underpins the next wave of generative AI models.
Biotech and neurotechnology also featured prominently. Boulder-based Enveda, an AI-enabled drug discovery startup, closed a $311 million Series E led by Catalio Capital Management, lifting its lifetime funding to more than $845 million. In New York, Precision Neuroscience secured $250 million in Series D financing with Pershing Square and the Ackman Oxman Institute as lead investors, advancing its brain-computer interface platform aimed at therapeutic and augmentative applications.
Other notable deals included Hubble Network’s $200 million Series C, which valued the Seattle satellite-connectivity provider at $1.6 billion, and Rightway’s $155 million Series E led by Francisco Partners to expand AI-driven pharmacy benefit services. The week also saw three $100 million rounds: Rainmaker, a cloud-seeding startup, attracted investors such as Upfront Ventures and DCVC; Numeral, an AI-powered sales-tax compliance platform, raised a Series C led by Insight Partners; and Micro1, a provider of AI training data, reportedly secured over $100 million at a $4 billion valuation.
The concentration of mega-funding in cybersecurity reflects heightened enterprise concerns over data protection as AI agents gain broader access to internal systems. For founders, the depth of capital available suggests that scaling through multiple financing stages remains viable, particularly for companies that can demonstrate clear revenue traction and strategic relevance to high-growth sectors. Investors appear to be rewarding firms that combine robust technology stacks with clear pathways to monetization, a pattern that may shape fundraising strategies throughout 2026.
Looking ahead, the breadth of sectors represented, from secure data platforms to neurotech and atmospheric engineering, indicates that venture capital is still willing to back ambitious, capital-intensive visions. Founders will need to balance rapid growth with sustainable unit economics, while investors will likely scrutinize the scalability of AI-driven models and the regulatory landscape surrounding emerging technologies. The coming months will reveal whether this week’s funding frenzy translates into lasting market leadership for the highlighted companies.